. "European Patent Office" . . . "[BD368682F34E]" . . "Deriv\u00E1ty Azapurinu"@cs . "RIV/61389030:_____/04:00000301!RIV/2005/AV0/A56005/N" . "\u00DAstav experiment\u00E1ln\u00ED botaniky AV \u010CR" . . . "Kry\u0161tof, Vladim\u00EDr" . "M\u00FCnchen" . "RIV/61389030:_____/04:00000301" . "Strnad, Miroslav" . "555749" . . . "Deriv\u00E1ty Azapurinu"@cs . "5"^^ . "Azapurine Derivatives" . "Azapurine Derivatives"@en . . . "5"^^ . "The present invention relates to a compound of formula (I), or a pharmaceutically acceptable acid salt thereof. The invention further relates to the use of said compounds in the treatment of hyperproliferative skin disorders, viral infections, cancer, rheumatoid arthritis, lupus, type I diabetes, multiple sclerosis, restenosis, polycystic kidney disease, graft rejection, graft versus host disease and gout, or for psoriasis, parasitoses such as those caused by fungi or protists, or Alzheimer's disease. Further aspects of the invention relate to the use of such compounds in the inhibition of cell proliferation, in the induction of apoptosis, to modulate the activity of adrenergic and/or purinergic receptors or to suppress immunostimulation. The invention also relates to the use of 2,6,9-trisubstituted 8-azapurines in maintaining mammalian ooctyes at the germinal vesicle stage." . . . . . . "Z(AV0Z5038910), Z(MSM 153100008)" . "2003-09-06+02:00"^^ . . . "Fuksov\u00E1, Kv\u011Btoslava" . "Deriv\u00E1ty Azapurinu"@cs . "The present invention relates to a compound of formula (I), or a pharmaceutically acceptable acid salt thereof. The invention further relates to the use of said compounds in the treatment of hyperproliferative skin disorders, viral infections, cancer, rheumatoid arthritis, lupus, type I diabetes, multiple sclerosis, restenosis, polycystic kidney disease, graft rejection, graft versus host disease and gout, or for psoriasis, parasitoses such as those caused by fungi or protists, or Alzheimer's disease. Further aspects of the invention relate to the use of such compounds in the inhibition of cell proliferation, in the induction of apoptosis, to modulate the activity of adrenergic and/or purinergic receptors or to suppress immunostimulation. The invention also relates to the use of 2,6,9-trisubstituted 8-azapurines in maintaining mammalian ooctyes at the germinal vesicle stage."@en . . "Havl\u00ED\u010Dek, Libor" . . "Azapurine Derivatives"@en . "2004-02-05+01:00"^^ . . "WO2004018473" . "Azapurine"@en . "Azapurine Derivatives" . . "Lenobel, Ren\u00E9" . .